No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
LLY250117P780000
- 5.98
- -4.59-43.42%
15min DelayClose Jan 10 16:00 ET
10.20High5.93Low
9.34Open10.57Pre Close615 Volume2.28K Open Interest780.00Strike Price464.08KTurnover39.97%IV3.24%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry5.98Extrinsic Value100Contract SizeAmericanOptions Type-0.2717Delta0.0095Gamma133.87Leverage Ratio-1.3549Theta-0.0252Rho-36.38Eff Leverage0.2910Vega
Intraday
- 5D
- Daily
News
Express News | Eli Lilly Sues Thrive Health and Wellness LLC & Valhalla Vitality LLC for Sale of Unapproved Tirzepatide Products- Court Filing
AI Trader Outperformed in 2024. Nvidia, Tesla, and Broadcom Are Some of Its Favorites.
Market Chatter: Eli Lilly Eyes $2.5 Billion Deal for Scorpion Therapeutics
Eli Lilly (NYSE:LLY) Shareholders Have Earned a 44% CAGR Over the Last Five Years
Can 2025 J.P. Morgan Healthcare Conference Spark Biotech M&A?
Key Deals This Week: FuboTV - Disney, Constellation Energy, Eli Lilly, Phillips 66, Intercontinental Exchange and More